Chemoinformaics analysis of 1-(Dimethoxymethyl)-4-methoxybenzene
| Molecular Weight | 182.219 | nRot | 4 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 6 |
| Exact Molecular Weight | 182.094 | nRing | 1 |
| Solubility: LogS | -1.648 | nHRing | 0 |
| Solubility: LogP | 1.601 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 28.4411 |
| nHD | 0 | BPOL | 19.2529 |
| QED | 0.666 |
| Synth | 1.937 |
| Natural Product Likeliness | -0.131 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.021 |
| Pgp-sub | 0.038 |
| HIA | 0.003 |
| CACO-2 | -4.231 |
| MDCK | 0.0000364 |
| BBB | 0.847 |
| PPB | 0.55083 |
| VDSS | 1.448 |
| FU | 0.299268 |
| CYP1A2-inh | 0.055 |
| CYP1A2-sub | 0.748 |
| CYP2c19-inh | 0.148 |
| CYP2c19-sub | 0.856 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.327 |
| CYP2d6-inh | 0.046 |
| CYP2d6-sub | 0.877 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.498 |
| CL | 7.421 |
| T12 | 0.226 |
| hERG | 0.024 |
| Ames | 0.128 |
| ROA | 0.036 |
| SkinSen | 0.314 |
| Carcinogencity | 0.558 |
| EI | 0.992 |
| Respiratory | 0.027 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.873919 |